Abiopharma

(99% Neutral) DARE BIOSCIENCE, INC. (DARE) Files Form 8-K

SAB BIO to Present at the 44th Annual J.P. Morgan Healthcare Conference

TransCode Therapeutics Announces Publication of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Glioblastoma

Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter

(90% Positive) Compass Therapeutics, Inc. (CMPX) Announces Enrollment Update for observed Due to Patient Enrollment Issues, Regulatory Process, Safety Review

Nortech Systems Names Andrew Walko Senior Vice President of Global Operations

(99% Neutral) NORTECH SYSTEMS INCORPORATED (NSYS) Files Form 8-K

(99% Neutral) EARTH SCIENCE TECH, INC. (ETST) Files Form 8-K

Thermo Fisher Scientific - Thermo Fisher Scientific to Present at the J.P. Morgan 2026 Healthcare Conference

Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer

Mineralys Therapeutics Provides Corporate Update and Announces Participation in Upcoming LifeSci Partners Corporate Access Event in January 2026

Elanco to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Edgewise Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026

Taysha Gene Therapies Announces Progress Across TSHA-102 Pivotal Gene Therapy Program in Rett Syndrome

NuCana Appoints Theresa Bruce as Chief Operating Officer